Gyre Therapeutics, Inc. (GYRE)
Total Valuation
GYRE has a market cap or net worth of $19.42 million. The enterprise value is -$13.68 million.
Market Cap | 19.42M |
Enterprise Value | -13.68M |
Important Dates
The last earnings date was Tuesday, March 26, 2024, before market open.
Earnings Date | Mar 26, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GYRE has 85.37 million shares outstanding. The number of shares has decreased by -13.02% in one year.
Shares Outstanding | 85.37M |
Shares Change (YoY) | -13.02% |
Shares Change (QoQ) | +2,500.21% |
Owned by Insiders (%) | 27.73% |
Owned by Institutions (%) | 8.75% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.17 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | 1.08 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.85
Current Ratio | 2.85 |
Quick Ratio | 2.75 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 0.02 |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -235.80% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $16.21M |
Profits Per Employee | -$13.28M |
Employee Count | 7 |
Asset Turnover | 2.88 |
Inventory Turnover | 0.89 |
Taxes
In the past 12 months, GYRE has paid $8.52 million in taxes.
Income Tax | 8.52M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +513.33% in the last 52 weeks. The beta is 1.29, so GYRE's price volatility has been higher than the market average.
Beta (1Y) | 1.29 |
52-Week Price Change | +513.33% |
50-Day Moving Average | 16.77 |
200-Day Moving Average | 12.37 |
Relative Strength Index (RSI) | 48.75 |
Average Volume (30 Days) | 85,055 |
Short Selling Information
The latest short interest is 34,049, so 0.04% of the outstanding shares have been sold short.
Short Interest | 34,049 |
Short Previous Month | 71,894 |
Short % of Shares Out | 0.04% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, GYRE had revenue of $113.45 million and -$92.93 million in losses. Loss per share was -$1.41.
Revenue | 113.45M |
Gross Profit | 108.81M |
Operating Income | -67.23M |
Pretax Income | -84.42M |
Net Income | -92.93M |
EBITDA | -82.99M |
EBIT | -84.42M |
Loss Per Share | -$1.41 |
Balance Sheet
The company has $33.51 million in cash and $409,000 in debt, giving a net cash position of $33.10 million or $0.39 per share.
Cash & Cash Equivalents | 33.51M |
Total Debt | 409,000 |
Net Cash | 33.10M |
Net Cash Per Share | $0.39 |
Equity / Book Value | -15.83M |
Book Value Per Share | -0.19 |
Working Capital | 37.17M |
Cash Flow
In the last 12 months, operating cash flow was $25.89 million and capital expenditures -$7.85 million, giving a free cash flow of $18.04 million.
Operating Cash Flow | 25.89M |
Capital Expenditures | -7.85M |
Free Cash Flow | 18.04M |
FCF Per Share | $0.27 |
Margins
Gross margin is 95.91%, with operating and profit margins of -59.26% and -81.92%.
Gross Margin | 95.91% |
Operating Margin | -59.26% |
Pretax Margin | -74.41% |
Profit Margin | -81.92% |
EBITDA Margin | -73.15% |
EBIT Margin | -74.41% |
FCF Margin | 15.90% |
Dividends & Yields
GYRE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 13.02% |
Shareholder Yield | 13.02% |
Earnings Yield | -478.59% |
FCF Yield | 92.90% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 13, 2017. It was a reverse split with a ratio of 1:15.
Last Split Date | Feb 13, 2017 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
GYRE has an Altman Z-Score of -1.76 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.76 |
Piotroski F-Score | 4 |